These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38769317)

  • 1. An antifouling membrane-fusogenic liposome for effective intracellular delivery in vivo.
    Kong H; Zheng C; Yi K; Mintz RL; Lao YH; Tao Y; Li M
    Nat Commun; 2024 May; 15(1):4267. PubMed ID: 38769317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.
    Hara T; Kuwasawa H; Aramaki Y; Takada S; Koike K; Ishidate K; Kato H; Tsuchiya S
    Biochim Biophys Acta; 1996 Jan; 1278(1):51-8. PubMed ID: 8611607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes.
    Tu Y; Kim JS
    J Gene Med; 2008 Jun; 10(6):646-54. PubMed ID: 18383507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery.
    Mo R; Jiang T; Gu Z
    Angew Chem Int Ed Engl; 2014 Jun; 53(23):5815-20. PubMed ID: 24764317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Functional Composition of Fusogenic Liposomes.
    Kolašinac R; Kleusch C; Braun T; Merkel R; Csiszár A
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of novel drug delivery system, fusogenic liposome, for cancer therapy].
    Kunisawa J; Mayumi T
    Gan To Kagaku Ryoho; 2001 May; 28(5):577-83. PubMed ID: 11383204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the observation of membrane fusion with label-free liposomes by calcium imaging.
    Hotta M; Hayase K; Kitanaka A; Li T; Takeoka S
    Biochem Biophys Rep; 2023 Jul; 34():101483. PubMed ID: 37250982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid rafts-mediated endocytosis and physiology-based cell membrane traffic models of doxorubicin liposomes.
    Li Y; Gao L; Tan X; Li F; Zhao M; Peng S
    Biochim Biophys Acta; 2016 Aug; 1858(8):1801-11. PubMed ID: 27117641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
    Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
    Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene delivery mediated by cationic liposomes: from biophysical aspects to enhancement of transfection.
    de Lima MC; Simões S; Pires P; Gaspar R; Slepushkin V; Düzgüneş N
    Mol Membr Biol; 1999; 16(1):103-9. PubMed ID: 10332744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex Size and Surface Charge Determine Nucleic Acid Transfer by Fusogenic Liposomes.
    Hoffmann M; Hersch N; Gerlach S; Dreissen G; Springer R; Merkel R; Csiszár A; Hoffmann B
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32213928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-fusogenic biomimetic particles: a new bioengineering tool learned from nature.
    Kong H; Yi K; Zheng C; Lao YH; Zhou H; Chan HF; Wang H; Tao Y; Li M
    J Mater Chem B; 2022 Sep; 10(36):6841-6858. PubMed ID: 35781483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanistic explanation of the inhibitory role of the protein corona on liposomal gene expression.
    Palchetti S; Digiacomo L; Giulimondi F; Pozzi D; Peruzzi G; Ferri G; Amenitsch H; Cardarelli F; Mahmoudi M; Caracciolo G
    Biochim Biophys Acta Biomembr; 2020 Mar; 1862(3):183159. PubMed ID: 31857070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein.
    Somiya M; Sasaki Y; Matsuzaki T; Liu Q; Iijima M; Yoshimoto N; Niimi T; Maturana AD; Kuroda S
    J Control Release; 2015 Aug; 212():10-8. PubMed ID: 26074149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
    Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
    Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Distribution of Lipids and Encapsulated Model Drugs from Cationic Liposomes with Different Uptake Pathways.
    Takikawa M; Fujisawa M; Yoshino K; Takeoka S
    Int J Nanomedicine; 2020; 15():8401-8409. PubMed ID: 33149583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical properties of CDAN/DOPE-analogue lipoplexes account for enhanced gene delivery.
    Fletcher S; Ahmad A; Price WS; Jorgensen MR; Miller AD
    Chembiochem; 2008 Feb; 9(3):455-63. PubMed ID: 18186098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transferrin as a ligand of pH-sensitive fusogenic liposome-lipoplex hybrid complexes.
    Sakaguchi N; Kojima C; Harada A; Koiwai K; Emi N; Kono K
    Bioconjug Chem; 2008 Aug; 19(8):1588-95. PubMed ID: 18627196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorothioated DNA Engineered Liposomes as a General Platform for Stimuli-Responsive Cell-Specific Intracellular Delivery and Genome Editing.
    Yan A; Chen X; He J; Ge Y; Liu Q; Men D; Xu K; Li D
    Angew Chem Int Ed Engl; 2023 Jun; 62(25):e202303973. PubMed ID: 37100742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusogenic liposome-enhanced cytosolic delivery of magnetic nanoparticles.
    Chen F; Bian M; Nahmou M; Myung D; Goldberg JL
    RSC Adv; 2021 Nov; 11(57):35796-35805. PubMed ID: 35492766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.